Self-Reported Attitudes of Elite Athletes Towards Doping: Differences Between Type of Sport

Abstract

Although athletes' beliefs and values are known to influence whether or not an athlete will use banned drugs, little is known about the athletes' beliefs and attitudes in different sports. The aim of this study was to clarify the beliefs and attitudes of elite athletes towards banned substances and methods in sports. A total of 446 athletes (response rate 90.3 %; 446/494) financially supported by the National Finnish Olympic Committee completed a structured questionnaire during their national team camps in 2002. More than 90 % of the athletes reported to believe that banned substances and methods have performance enhancing effects, and 30 % reported that they personally know an athlete who uses banned substances. Of the male athletes 35 %, and 23 % of females reported they personally know an athlete using banned substances. A total of 15 % of the athletes reported that they had been offered banned substances: 21 % of the speed and power athletes, 14 % of the team sport athletes and of the athletes in motor skills demanding events, and 10 % of the endurance athletes. Stimulants were the most often offered substance group (to 7 % of all the athletes) followed by anabolic steroids (4 %). Subjects who regarded doping as a minor health risk seemed to be more often associated with doping users than those regarding doping as a significant health risk. Athletes in different sports have a different approach to doping. Risk of doping appears to be highest in speed and power sports and lowest in motor skills demanding sports. Males are at higher risk than females. Controlling doping only by tests is not sufficient. A profound change in the attitudes is needed, which should be monitored repeatedly.

Elite athlete - doping - attitude - type of sport - banned drugs

References

• 1 Alaranta A, Alaranta H, Palmu P, Alha P, Pietilä K, Heliövaara M, Helenius I. Asthma medication in Finnish Olympic athletes: No signs of inhaled β₂-agonist overuse.  Med Sci Sports Exerc. 2004;  36 919-924
• 2 Bents R T, Tokish J M, Goldberg L. Ephedrine, pseudoephedrine, and amphetamine prevalence in college hockey players.  Physician Sportsmed. 2004;  32 30-34
• 3 European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) .Statistical Bulletin. Lisbon; EMCDDA 2004
• 4 Goldberg L, Elliott D, Clarke G N. et al . Effects of a multidimensional anabolic steroid prevention intervention: The adolescents training and learning to avoid steroids (ATLAS) program.  JAMA. 1996;  276 1555-1562
• 5 Green G A, Uryasz F D, Petr T A, Bray C D. NCAA study of substance use and abuse habits of college student-athletes.  Clin J Sport Med. 2001;  11 51-56
• 6 Karila T. Adverse effects of anabolic androgenic steroids on the cardiovascular, metabolic and reproductive systems of anabolic substance abusers. University of Helsinki, Faculty of Medicine; Academic Dissertation 2003
• 7 Kindlundh A, Isacson D, Berglund L. et al . Factors associated with adolescent use of doping agents: anabolic-androgenic steroids.  Addiction. 1999;  94 543-553
• 8 Laure P, Lecerf T, Friser A, Binsinger C. Drugs, recreational drug use and attitudes towards doping of high school athletes.  Int J Sports Med. 2004;  25 133-138
• 9 Laure P, Binsinger C, Lecerf T. General practitioners and doping in sport: attitudes and experience.  Br J Sports Med. 2003;  37 335-338
• 10 Laure P, Thouvenin F, Lecerf T. Attitudes of coaches towards doping.  J Sports Med Phys Fitness. 2001;  41 132-136
• 11 Laure P, Kriebitzsch-Lejeune A. Retail pharmacists and doping in sports: knowledge and attitudes. A national survey in France.  Sci Sports. 2000;  15 141-146
• 12 Laure P. Epidemiologic approach of doping in sport.  J Sports Med Phys Fitness. 1997;  37 218-224
• 13 Laure P, Reinsberger H. Doping and high-level endurance walkers. Knowledge and representation of a prohibited practise.  J Sports Med Phys Fitness. 1995;  35 228-231
• 14 Mottram D R. Banned drugs in sport. Does the International Olympic Committee (IOC) list need updating?.  Sports Med. 1999;  27 1-10
• 15 Nilsson S, Baigi A, Marklund B. et al . The prevalence of the use of androgenic steroids by adolescents in a county of Sweden.  Eur J Public Health. 2001;  11 195-197
• 16 Nilsson S. Androgenic anabolic steroid use among male adolescents in Falkenberg.  Eur J Clin Pharmacol. 1995;  48 9-11
• 17 Scarpino V, Arrigo A, Benzi G. et al . Evaluation of prevalence “doping” among Italian athletes.  Lancet. 1990;  336 1048-1050
• 18 Waddington I, Malcolm D, Roderick M, Naik R. Drug use in English professional football.  Br J Sports Med. 2005;  39 e-18
• 19 World Anti-Doping Agency .The World Anti-Doping Code. Montreal; WADA 2003
• 20 Yesalis C E, Bahrke M S. Anabolic-androgenic steroids.  Sports Med. 1995;  19 326-340
• 21 Yesalis C, Buckley W, Anderson W. et al . Athletes' projections of anabolic steroid use.  Clin Sports Med. 1990;  2 155-171